Question 1

Who is Andrew J. Murphy?

Accepted Answer

Andrew J. Murphy serves as Executive at REGENERON PHARMACEUTICALS, INC. (REGN). They have executed 257 insider transactions totaling $57.6M over their tenure at the company.

Question 2

What is Andrew J. Murphy's role at REGENERON PHARMACEUTICALS, INC.?

Accepted Answer

Andrew J. Murphy holds the position of Executive at REGENERON PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.

Question 3

Is Andrew J. Murphy buying or selling REGN stock?

Accepted Answer

Andrew J. Murphy has shown a selling trading pattern, with $0 in total purchases and $57.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Andrew J. Murphy's largest insider transactions?

Accepted Answer

The largest transaction by Andrew J. Murphy was on Oct 29, 2025, when they sold $21.1M worth of REGN shares. This transaction involved 32,490 shares at $648.82 per share.

Question 5

What is Andrew J. Murphy's trading accuracy?

Accepted Answer

Andrew J. Murphy has a Personal Accuracy Score of 95/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Andrew J. Murphy associated with?

Accepted Answer

Andrew J. Murphy has filed Form 4 transactions for 1 different company. Their primary association is with REGENERON PHARMACEUTICALS, INC. (REGN), where they serve as Executive.

Question 7

How much REGN stock does Andrew J. Murphy own?

Accepted Answer

Andrew J. Murphy currently owns 47,833 shares of REGENERON PHARMACEUTICALS, INC. (REGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Andrew J. Murphy's equity in REGENERON PHARMACEUTICALS, INC.?

Accepted Answer

Andrew J. Murphy's equity position in REGENERON PHARMACEUTICALS, INC. consists of 47,833 shares valued at approximately $0. As Executive, they have executed 257 insider transactions, with $0 in purchases and $57.6M in sales.

Question 9

Where can I find Andrew J. Murphy's SEC Form 4 filings?

Accepted Answer

All of Andrew J. Murphy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew J. Murphy has 257 Form 4 filings on record as an insider at REGENERON PHARMACEUTICALS, INC..

Question 10

What is Andrew J. Murphy's net worth from REGN?

Accepted Answer

Based on their current REGN stock holdings, Andrew J. Murphy has equity worth approximately $0 in REGENERON PHARMACEUTICALS, INC.. This value is based on 47,833 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Dec 9, 2025	REGN	$3.0M	Payment	4,229	$701.51	Discretionary
Dec 8, 2025	REGN	$1.2M	Payment	1,699

Andrew J. Murphy

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Andrew J. Murphy Trading Summary

How Much REGN Stock Does Andrew J. Murphy Own?

Is Andrew J. Murphy Buying or Selling REGN?

Andrew J. Murphy's Recent Stock Transactions

Frequently Asked Questions

Track Andrew J. Murphy's Trades